Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent ...
Dietmar Berger is Gilead’s new CMO; Padlock investors sue Bristol Myers
Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, ...
FierceBiotech9h
Gilead's Daniel O'Day relishes Dietmar Berger reunion as cancer specialist agrees to join from Sanofi
Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...
Gilead appoints Dietmar Berger as Chief Medical Officer
Gilead (GILD) announced that Dietmar Berger will join the company on January 2, 2025, as Chief Medical Officer and will become a member of ...
The Pharma Letter7h
Gilead Sciences names new CMO
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief ...
Daily8h
Gilead Sciences ropes in Sanofi official Dietmar Berger as new Chief Medical Officer
Gilead Sciences, Inc. has announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical ...
Gilead Sciences Names Sanofi's Berger as Next Chief Medical Officer
Gilead Sciences named former Sanofi executive Dietmar Berger as chief medical officer, effective Jan. 2, succeeding Merdad Parsey.
Le Lézard20h
Vitamin D Testing Market to Grow by USD 182.6 Million from 2023-2028, Report on AI-Powered Market Evolution - Technavio
Report on how AI is driving market transformation - The global vitamin D testing market size is estimated to grow by USD ...
Le Lézard19h
WMCHealth Names David Lubarsky, MD, MBA, FASA, as Network President and Chief Executive Officer
Board of Directors announced today that, after a nationwide search, David Lubarsky, MD, MBA, FASA, will be the next President ...
Le Lézard19h
HVAC Market: 53% of Growth to Come from APAC, Report on AI-Driven Market Transformation - Technavio
Report with the AI impact on market trends - The global HVAC market size is estimated to grow by USD 74.02 billion from 2024 ...
Le Lézard19h
2024 SABCS?Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, ...